$2.14 Billion is the total value of Eventide Asset Management's 144 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 18.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A Ssponsored adr | $87,148,000 | +63.3% | 1,332,540 | 0.0% | 4.08% | +46.6% | |
| XPO | XPO LOGISTICS INC | $80,226,000 | +11.2% | 788,000 | 0.0% | 3.76% | -0.2% | |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $56,404,000 | +38.4% | 2,207,610 | 0.0% | 2.64% | +24.3% | |
| AVXS | AVEXIS INC | $52,027,000 | +11.7% | 421,000 | 0.0% | 2.44% | +0.3% | |
| AIMT | Buy | AIMMUNE THERAPEUTICS INC | $49,813,000 | +7.4% | 1,564,983 | +27.6% | 2.33% | -3.5% |
| LOW | LOWES COS INC | $49,579,000 | -5.6% | 565,000 | 0.0% | 2.32% | -15.2% | |
| BLUE | BLUEBIRD BIO INC | $47,401,000 | -4.1% | 277,603 | 0.0% | 2.22% | -13.9% | |
| LRCX | LAM RESEARCH CORP | $46,117,000 | +10.4% | 227,000 | 0.0% | 2.16% | -0.9% | |
| SPLK | Buy | SPLUNK INC | $44,571,000 | +62.5% | 453,000 | +36.9% | 2.09% | +46.0% |
| ABBV | ABBVIE INC | $42,309,000 | -2.1% | 447,000 | 0.0% | 1.98% | -12.1% | |
| W | WAYFAIR INCcl a | $42,274,000 | -15.9% | 626,000 | 0.0% | 1.98% | -24.4% | |
| SAGE | Buy | SAGE THERAPEUTICS INC | $40,268,000 | +32.4% | 250,000 | +35.4% | 1.88% | +18.9% |
| INST | Buy | INSTRUCTURE INC | $39,705,000 | +42.5% | 942,000 | +11.9% | 1.86% | +27.9% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $39,604,000 | +46.8% | 243,000 | +35.0% | 1.85% | +31.9% |
| MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $38,112,000 | -19.5% | 1,032,000 | +40.0% | 1.78% | -27.7% |
| HUBS | Buy | HUBSPOT INC | $37,905,000 | +106.2% | 350,000 | +68.3% | 1.78% | +85.1% |
| WCN | WASTE CONNECTIONS INC | $37,090,000 | +1.1% | 517,000 | 0.0% | 1.74% | -9.2% | |
| MGA | Buy | MAGNA INTL INC | $34,852,000 | +0.8% | 618,500 | +1.4% | 1.63% | -9.4% |
| LEA | LEAR CORP | $34,241,000 | +5.3% | 184,000 | 0.0% | 1.60% | -5.4% | |
| WBC | WABCO HLDGS INC | $34,217,000 | -6.7% | 255,600 | 0.0% | 1.60% | -16.2% | |
| ASML | ASML HOLDING N V | $34,152,000 | +14.2% | 172,000 | 0.0% | 1.60% | +2.6% | |
| CCI | CROWN CASTLE INTL CORP NEW | $33,431,000 | -1.3% | 305,000 | 0.0% | 1.56% | -11.3% | |
| STLD | Sell | STEEL DYNAMICS INC | $33,342,000 | -11.2% | 754,000 | -13.4% | 1.56% | -20.3% |
| KAR | KAR AUCTION SVCS INC | $33,062,000 | +7.3% | 610,000 | 0.0% | 1.55% | -3.6% | |
| CELG | Buy | CELGENE CORP | $32,205,000 | +12.5% | 361,000 | +31.6% | 1.51% | +1.1% |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $32,080,000 | -4.9% | 802,200 | +2.5% | 1.50% | -14.6% |
| STKL | Buy | SUNOPTA INC | $30,534,000 | +1.0% | 4,300,540 | +10.2% | 1.43% | -9.3% |
| SGEN | Buy | SEATTLE GENETICS INC | $29,153,000 | +3.8% | 557,000 | +6.1% | 1.36% | -6.8% |
| VRNS | Buy | VARONIS SYS INC | $28,980,000 | +255.3% | 479,000 | +185.1% | 1.36% | +219.3% |
| FIVN | Buy | FIVE9 INC | $26,632,000 | +85.8% | 894,000 | +55.2% | 1.25% | +66.9% |
| LOXO | Sell | LOXO ONCOLOGY INC | $26,420,000 | +10.1% | 229,000 | -19.6% | 1.24% | -1.1% |
| IDTI | INTEGRATED DEVICE TECHNOLOGY | $25,243,000 | +2.8% | 826,000 | 0.0% | 1.18% | -7.7% | |
| GTTN | Buy | GTT COMMUNICATIONS INC | $25,005,000 | +1161.0% | 441,000 | +943.9% | 1.17% | +1036.9% |
| SNA | Buy | SNAP ON INC | $24,266,000 | -15.3% | 164,470 | +0.1% | 1.14% | -23.9% |
| LII | Buy | LENNOX INTL INC | $24,116,000 | +54.4% | 118,000 | +57.3% | 1.13% | +38.7% |
| ARW | ARROW ELECTRS INC | $22,721,000 | -4.2% | 295,000 | 0.0% | 1.06% | -14.0% | |
| ELLI | ELLIE MAE INC | $22,249,000 | +2.8% | 242,000 | 0.0% | 1.04% | -7.6% | |
| XLRN | Sell | ACCELERON PHARMA INC | $20,719,000 | -25.3% | 529,900 | -19.0% | 0.97% | -33.0% |
| JELD | Buy | JELD-WEN HLDG INC | $19,722,000 | -1.1% | 644,100 | +27.2% | 0.92% | -11.2% |
| PANW | Buy | PALO ALTO NETWORKS INC | $18,878,000 | +44.7% | 104,000 | +15.6% | 0.88% | +30.0% |
| CAFD | Buy | 8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt | $18,876,000 | -15.1% | 1,553,600 | +6.3% | 0.88% | -23.7% |
| ONCE | Sell | SPARK THERAPEUTICS INC | $17,979,000 | +7.9% | 270,000 | -16.7% | 0.84% | -3.0% |
| PFPT | PROOFPOINT INC | $17,957,000 | +28.0% | 158,000 | 0.0% | 0.84% | +15.0% | |
| PEGI | Buy | PATTERN ENERGY GROUP INCcl a | $17,887,000 | -18.8% | 1,034,500 | +1.0% | 0.84% | -27.1% |
| TTD | Sell | THE TRADE DESK INC | $17,863,000 | -43.3% | 360,000 | -47.8% | 0.84% | -49.1% |
| ANET | New | ARISTA NETWORKS INC | $16,850,000 | – | 66,000 | +100.0% | 0.79% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $16,744,000 | +86.9% | 226,000 | +40.4% | 0.78% | +67.9% |
| IPHI | INPHI CORP | $16,706,000 | -17.8% | 555,000 | 0.0% | 0.78% | -26.2% | |
| APTV | Buy | APTIV PLC | $16,697,000 | +24.6% | 196,500 | +24.4% | 0.78% | +11.9% |
| STML | STEMLINE THERAPEUTICS INC | $16,622,000 | -1.9% | 1,086,400 | 0.0% | 0.78% | -11.9% | |
| ROP | New | ROPER TECHNOLOGIES INC | $16,561,000 | – | 59,000 | +100.0% | 0.78% | – |
| AY | Buy | ATLANTICA YIELD PLC | $16,202,000 | -5.2% | 827,500 | +2.7% | 0.76% | -14.8% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $15,158,000 | -0.4% | 378,000 | -12.8% | 0.71% | -10.5% |
| CRUS | CIRRUS LOGIC INC | $15,033,000 | -21.7% | 370,000 | 0.0% | 0.70% | -29.6% | |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $14,557,000 | +19.0% | 178,000 | -16.8% | 0.68% | +6.9% |
| HASI | Buy | HANNON ARMSTRONG SUST INFR C | $14,118,000 | -15.8% | 724,000 | +3.8% | 0.66% | -24.4% |
| BPMC | BLUEPRINT MEDICINES CORP | $13,755,000 | +21.6% | 150,000 | 0.0% | 0.64% | +9.2% | |
| VYGR | VOYAGER THERAPEUTICS INC | $13,217,000 | +13.2% | 703,425 | 0.0% | 0.62% | +1.6% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $12,937,000 | +6.9% | 156,000 | 0.0% | 0.61% | -4.0% | |
| VMC | VULCAN MATLS CO | $12,559,000 | -11.1% | 110,000 | 0.0% | 0.59% | -20.1% | |
| TWLO | Sell | TWILIO INCcl a | $12,485,000 | -8.0% | 327,000 | -43.1% | 0.58% | -17.3% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $12,199,000 | +74.8% | 573,553 | +3.9% | 0.57% | +56.9% |
| VCYT | VERACYTE INC | $11,862,000 | -14.9% | 2,133,500 | 0.0% | 0.56% | -23.6% | |
| ZGNX | Buy | ZOGENIX INC | $10,613,000 | +57.7% | 265,000 | +57.7% | 0.50% | +41.6% |
| DOOR | MASONITE INTL CORP NEW | $10,430,000 | -17.3% | 170,000 | 0.0% | 0.49% | -25.7% | |
| PAYC | Buy | PAYCOM SOFTWARE INC | $10,309,000 | +598.0% | 96,000 | +422.3% | 0.48% | +527.3% |
| FENC | FENNEC PHARMACEUTICALS INC | $8,961,000 | +21.3% | 741,175 | 0.0% | 0.42% | +9.1% | |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $8,913,000 | +36.5% | 346,000 | +43.0% | 0.42% | +22.6% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $8,532,000 | +23.4% | 900,000 | +26.9% | 0.40% | +10.8% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $8,114,000 | +15.4% | 270,000 | +20.0% | 0.38% | +3.5% |
| ARGX | New | ARGENX SEsponsored adr | $8,044,000 | – | 100,000 | +100.0% | 0.38% | – |
| TSLA | TESLA INC | $7,984,000 | -14.5% | 30,000 | 0.0% | 0.37% | -23.2% | |
| IFRX | INFLARX NV | $7,931,000 | +37.7% | 275,000 | 0.0% | 0.37% | +23.7% | |
| REGN | Buy | REGENERON PHARMACEUTICALS | $7,920,000 | +180.9% | 23,000 | +206.7% | 0.37% | +152.4% |
| QURE | New | UNIQURE NV | $7,873,000 | – | 335,000 | +100.0% | 0.37% | – |
| MYOK | Buy | MYOKARDIA INC | $7,418,000 | +60.2% | 152,000 | +38.2% | 0.35% | +44.0% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $7,398,000 | – | 394,585 | +100.0% | 0.35% | – |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $7,384,000 | -35.4% | 62,000 | -31.1% | 0.35% | -41.9% |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $7,260,000 | – | 400,000 | +100.0% | 0.34% | – |
| EXR | Buy | EXTRA SPACE STORAGE INC | $7,251,000 | +1.1% | 83,000 | +1.2% | 0.34% | -9.4% |
| GWPH | GW PHARMACEUTICALS PLCads | $7,155,000 | -14.6% | 63,500 | 0.0% | 0.34% | -23.3% | |
| XNCR | Sell | XENCOR INC | $6,835,000 | -0.4% | 228,000 | -27.2% | 0.32% | -10.6% |
| VBIV | VBI VACCINES INC | $6,475,000 | -18.0% | 1,850,000 | 0.0% | 0.30% | -26.5% | |
| CERN | CERNER CORP | $6,276,000 | -13.9% | 108,200 | 0.0% | 0.29% | -22.6% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $6,162,000 | -26.3% | 2,265,455 | 0.0% | 0.29% | -33.9% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $6,080,000 | -9.1% | 75,000 | 0.0% | 0.28% | -18.3% | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | $5,954,000 | +14.9% | 130,000 | 0.0% | 0.28% | +3.3% | |
| ATHN | ATHENAHEALTH INC | $5,292,000 | +7.5% | 37,000 | 0.0% | 0.25% | -3.5% | |
| EXAS | Buy | EXACT SCIENCES CORP | $5,283,000 | +0.6% | 131,000 | +31.0% | 0.25% | -9.9% |
| AKCA | Sell | AKCEA THERAPEUTICS INC | $4,482,000 | -38.5% | 175,000 | -58.3% | 0.21% | -44.7% |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $4,457,000 | +9.9% | 87,400 | 0.0% | 0.21% | -0.9% | |
| GLPG | Sell | GALAPAGOS NVspon adr | $3,990,000 | -18.2% | 40,000 | -23.1% | 0.19% | -26.4% |
| RGEN | REPLIGEN CORP | $3,980,000 | -0.3% | 110,000 | 0.0% | 0.19% | -10.6% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $3,922,000 | -6.2% | 170,000 | 0.0% | 0.18% | -15.6% | |
| MGNX | MACROGENICS INC | $3,699,000 | +32.4% | 147,000 | 0.0% | 0.17% | +18.5% | |
| ECYT | New | ENDOCYTE INC | $3,182,000 | – | 350,000 | +100.0% | 0.15% | – |
| BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $3,082,000 | +13.5% | 99,000 | +27.2% | 0.14% | +1.4% |
| SLDB | New | SOLID BIOSCIENCES INC | $3,000,000 | – | 400,000 | +100.0% | 0.14% | – |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $2,963,000 | +3.0% | 192,000 | 0.0% | 0.14% | -7.3% | |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $2,920,000 | – | 25,000 | +100.0% | 0.14% | – |
| DERM | Buy | DERMIRA INC | $2,669,000 | -22.6% | 334,000 | +169.4% | 0.12% | -30.6% |
| INCY | Buy | INCYTE CORP | $2,583,000 | +1.0% | 31,000 | +14.8% | 0.12% | -9.0% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $2,553,000 | -74.7% | 113,600 | -66.1% | 0.12% | -77.1% |
| DLPH | DELPHI TECHNOLOGIES PLC | $2,510,000 | -9.2% | 52,666 | 0.0% | 0.12% | -18.1% | |
| VICL | VICAL INC | $2,465,000 | -20.8% | 1,700,000 | 0.0% | 0.12% | -29.0% | |
| FHB | Buy | FIRST HAWAIIAN INC | $2,463,000 | +15.5% | 88,500 | +21.1% | 0.12% | +3.6% |
| ACRS | ACLARIS THERAPEUTICS INC | $2,453,000 | -28.9% | 140,000 | 0.0% | 0.12% | -36.1% | |
| AQXP | AQUINOX PHARMACEUTICALS INC | $2,464,000 | +19.7% | 175,000 | 0.0% | 0.12% | +7.5% | |
| JCI | Buy | JOHNSON CTLS INTL PLC | $2,343,000 | +17.1% | 66,500 | +26.7% | 0.11% | +5.8% |
| ABB | Buy | ABB LTDsponsored adr | $2,255,000 | +11.6% | 95,000 | +26.2% | 0.11% | +1.0% |
| HMC | Buy | HONDA MOTOR LTD | $2,049,000 | +10.6% | 59,000 | +8.6% | 0.10% | -1.0% |
| RARX | New | RA PHARMACEUTICALS INC | $2,060,000 | – | 388,000 | +100.0% | 0.10% | – |
| SYRS | SYROS PHARMACEUTICALS INC | $1,947,000 | +33.4% | 150,000 | 0.0% | 0.09% | +19.7% | |
| SEP | Sell | SPECTRA ENERGY PARTNERS LP | $1,850,000 | -25.1% | 55,000 | -12.0% | 0.09% | -32.6% |
| PTCT | PTC THERAPEUTICS INC | $1,845,000 | +62.1% | 68,200 | 0.0% | 0.09% | +45.8% | |
| Buy | ESSA PHARMA INC | $1,831,000 | +217.9% | 9,639,410 | +254.5% | 0.09% | +186.7% | |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $1,816,000 | +18.9% | 41,500 | +7.8% | 0.08% | +6.2% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $1,804,000 | -73.9% | 105,000 | -66.7% | 0.08% | -76.7% |
| TERP | New | TERRAFORM PWR INC | $1,728,000 | – | 161,000 | +100.0% | 0.08% | – |
| BDN | Buy | BRANDYWINE RLTY TRsh ben int new | $1,644,000 | +10.9% | 103,500 | +27.0% | 0.08% | 0.0% |
| BG | Buy | BUNGE LIMITED | $1,604,000 | +30.6% | 21,700 | +18.6% | 0.08% | +17.2% |
| TSRO | TESARO INC | $1,486,000 | -31.0% | 26,000 | 0.0% | 0.07% | -37.5% | |
| PRTA | Sell | PROTHENA CORP PLC | $1,358,000 | -69.8% | 37,000 | -69.2% | 0.06% | -72.8% |
| TNDM | New | TANDEM DIABETES CARE INC | $1,364,000 | – | 275,000 | +100.0% | 0.06% | – |
| ETN | Buy | EATON CORP PLC | $1,358,000 | +35.4% | 17,000 | +33.9% | 0.06% | +23.1% |
| MLHR | Buy | MILLER HERMAN INC | $1,304,000 | +2.7% | 40,800 | +28.7% | 0.06% | -7.6% |
| APU | Buy | AMERIGAS PARTNERS L Punit l p int | $1,279,000 | +10.6% | 32,000 | +28.0% | 0.06% | 0.0% |
| HANNON ARMSTRONG SUST INFR Cnote 4.125% 9/0 | $1,198,000 | -7.1% | 1,250,000 | 0.0% | 0.06% | -16.4% | ||
| CCIPRA | Buy | CROWN CASTLE INTL CORP NEW6.875% con pfd a | $1,115,000 | +30.9% | 990 | +31.1% | 0.05% | +18.2% |
| CVA | Buy | COVANTA HLDG CORP | $1,066,000 | +54.9% | 73,500 | +80.6% | 0.05% | +38.9% |
| NYLD | Buy | NRG YIELD INCcl c | $1,037,000 | +75.2% | 61,000 | +94.9% | 0.05% | +58.1% |
| WELL | Buy | WELLTOWER INC | $958,000 | +69.9% | 17,600 | +98.9% | 0.04% | +55.2% |
| VTR | Buy | VENTAS INC | $966,000 | +62.6% | 19,500 | +97.0% | 0.04% | +45.2% |
| MNLO | New | MENLO THERAPEUTICS INC | $940,000 | – | 25,000 | +100.0% | 0.04% | – |
| GPMT | New | GRANITE PT MTG TR INC | $918,000 | – | 55,500 | +100.0% | 0.04% | – |
| WBK | Buy | WESTPAC BKG CORPsponsored adr | $887,000 | +6.7% | 40,000 | +17.3% | 0.04% | -2.3% |
| CIG | Buy | COMPANHIA ENERGETICA DE MINAsp adr n-v pfd | $864,000 | +42.1% | 335,000 | +13.6% | 0.04% | +25.0% |
| ERIC | Buy | ERICSSONadr b sek 10 | $736,000 | +15.9% | 115,000 | +21.1% | 0.03% | +3.0% |
| LPT | Buy | LIBERTY PPTY TRsh ben int | $616,000 | +19.4% | 15,500 | +29.2% | 0.03% | +7.4% |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $621,000 | -64.4% | 63,000 | -49.6% | 0.03% | -68.1% |
| LXP | Buy | LEXINGTON REALTY TRUST | $630,000 | +18.6% | 80,000 | +45.5% | 0.03% | +3.6% |
| AYI | Buy | ACUITY BRANDS INC | $564,000 | -2.9% | 4,050 | +22.7% | 0.03% | -13.3% |
| ACORDA THERAPEUTICS INCnote 1.750% 6/1 | $366,000 | +7.3% | 400,000 | 0.0% | 0.02% | -5.6% | ||
| New | HERCULES CAPITAL INCdbcv 4.375% 2/0 | $203,000 | – | 200,000 | +100.0% | 0.01% | – | |
| CMTA | Exit | CLEMENTIA PHARMACEUTICALS IN | $0 | – | -60,000 | -100.0% | -0.06% | – |
| CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -172,000 | -100.0% | -0.06% | – |
| TERP | Exit | TERRAFORM PWR INC | $0 | – | -103,300 | -100.0% | -0.06% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -290,000 | -100.0% | -0.07% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -20,000 | -100.0% | -0.10% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -850,000 | -100.0% | -0.13% | – |
| NTUS | Exit | NATUS MEDICAL INC DEL | $0 | – | -75,000 | -100.0% | -0.15% | – |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS I | $0 | – | -463,700 | -100.0% | -0.15% | – |
| TCON | Exit | TRACON PHARMACEUTICALS INC | $0 | – | -900,000 | -100.0% | -0.16% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -275,000 | -100.0% | -0.30% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -0.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2018-05-18
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.